Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-26

Clinical Trial Update: Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole [NA]

View source ↗

Summary

A clinical study is evaluating cyclosporine, an androgen, and levamisole for non-severe aplastic anemia, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen
  • CYCLOSPORINE (cyclosporine)
  • Levamisole (levamisole)

Snippet

Sponsor: Shengyun Lin | Conditions: Aplastic Anemia | NA | Status: UNKNOWN